Castle Biosciences Inc (CSTL)

Shares of Castle Biosciences (CSTL) dropped by 4.05% from $13.57 to $13.02 in the trading on Wednesday, October 18, 2023. The reason why CSTL is down today is due to the company's announcement of new data presented at the 2023 Fall Clinical Dermatology Conference® (FC23). This data highlighted the clinical effectiveness of Castle Biosciences' dermatologic gene expression profile (GEP) tests for various skin conditions. Despite the positive data presentation, the stock may have faced market reactions or investor sentiment leading to the decline in its price.

Shares of Castle Biosciences (CSTL) dropped by 10.50% from $13.62 to $12.19 in the trading on Thursday, October 12, 2023. The reason why CSTL is down today is due to a broader market downturn triggered by fresh inflation data showing ongoing price pressures. Key highlights from the market:

• Stock prices declined, with all three major indexes dropping by 0.5% or more. The Dow industrials lost 174 points.
• Yields on 10-year U.S. Treasuries increased to 4.710% from 4.596% the previous day, while the two-year yield also rose as bond prices fell.
• Walgreens reported a narrower quarterly loss, resulting in a gain in its stock price. Delta shares fell despite the airline's year-on-year profit increase.
• Shares of food company Hormel plummeted, experiencing their worst day in over a decade. Homebuilders' shares retreated due to concerns about reduced demand caused by rising mortgage rates.
• Brent crude oil prices inched higher, settling at $86 a barrel and breaking a two-session losing streak. The Israel-Hamas conflict remained a focus for traders. Castle Biosciences' stock decline was part of a broader market trend influenced by economic data and market dynamics on that day.